Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$12,428,783
+$398,424 QoQ
Shares Held
48,938
-0.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
9.77%
of 13F equity value
Holder Rank
#982
of 4,676 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TFC Financial Management, Inc. holds $19,845,722 across 13 Drug Manufacturers - General names. JNJ ranks #1 (62.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
48,938 | $12,428,783 | |
| 2 | MRK |
Merck & Co., Inc.
|
38,730 | $4,976,805 | |
| 3 | LLY |
ELI LILLY & Co
|
877 | $1,051,900 | |
| 4 | ABBV |
AbbVie Inc.
|
3,399 | $855,324 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,053 | $133,036 | |
| 6 | NVS |
Novartis AG
|
576 | $90,270 | |
| 7 | NVO |
Novo Nordisk A S
|
1,619 | $77,614 | |
| 8 | AMGN |
Amgen Inc
|
200 | $72,424 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,428,783 | 48,938 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $12,030,359 | 49,216 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $10,312,318 | 49,830 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $9,241,147 | 49,839 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $7,758,478 | 50,792 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $8,440,592 | 50,896 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $7,433,178 | 51,398 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $8,349,331 | 51,520 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $7,566,557 | 51,769 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $8,526,124 | 53,898 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $8,466,311 | 54,015 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $8,499,900 | 54,574 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $9,279,547 | 56,063 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $8,678,450 | 55,990 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $9,972,952 | 56,456 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,420,807 | 57,669 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $10,081,680 | 56,795 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $10,246,552 | 57,815 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $10,015,635 | 58,547 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $9,599,398 | 59,439 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $9,632,842 | 58,473 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $9,719,823 | 59,141 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $9,944,999 | 63,191 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $9,589,509 | 64,411 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||